Showing results (7631-7640 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|February 10, 2012
The challenges involved in modeling toxicity data in silico: a reviewM Paul Gleeson, Sandeep Modi, Andreas Bender, et al.Current Pharmaceutical Design|February 10, 2012
Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinasesMichael J Schnieders, Tamer S Kaoud, Chunli Yan, et al.Current Pharmaceutical Design|February 10, 2012
Herbal medicines for the prevention and treatment of Alzheimer's diseaseHyo Geun Kim, Myung Sook OhCurrent Pharmaceutical Design|January 28, 2012
Glutamatergic animal models of schizophreniaCorina Bondi, Marguerite Matthews, Bita MoghaddamCurrent Pharmaceutical Design|January 28, 2012
Is dopamine neurotransmission altered in prodromal schizophrenia? A review of the evidenceMartin Bauer, Nicole Praschak-Rieder, Siegfried Kasper, et al.Current Pharmaceutical Design|January 28, 2012
Genetic data supporting the NMDA glutamate receptor hypothesis for schizophreniaThomas L Schwartz, Shilpa Sachdeva, Stephen M StahlCurrent Pharmaceutical Design|January 31, 2012
Renin-angiotensin antagonists: therapeutic effects beyond blood pressure control?Aldo Pende, Franco DallegriCurrent Pharmaceutical Design|April 20, 2012
Bioresorbable and nonresorbable polymers for bone tissue engineeringJordi Girones Molera, José Alberto Mendez, Julio San RomanCurrent Pharmaceutical Design|January 14, 2012
Reliability and validity of the Comprehensive Assessment of the At Risk Mental State, Italian version (CAARMS-I)P Fusar-Poli, R Hobson, M Raduelli, et al.Pageof 1,009